CD47 and cancer: Because we observed detectable surface SIRPγ protein expression in less than 10% of A549 and H1975 cells cultured under standard conditions, comprising the CSLC populations, we were puzzled to account for how SIRPγ might control CD47 expression by the large majority of (non-stem) cancer cells.